• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ReShape Lifesciences, Inc. - Common Stock (NQ:RSLS)

3.920 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ReShape Lifesciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
EXCLUSIVE: April's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Apple, Palantir, Nvidia Stocks Rank? ↗
May 02, 2025
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
News headline image
ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
May 02, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System
April 28, 2025
Patent Expands and Strengthens Intellectual Property Portfolio Around a Swallowable and Degradable Intragastric Device 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences Ignites Retail Frenzy As Stock Soars On US Patent For Diabetes Neuromodulation System ↗
April 21, 2025
The technology leverages ReShape’s proprietary vagus nerve block and stimulation platform to regulate blood glucose in patients with Type 2 diabetes by modulating nerve signals to the liver and... 
Via Stocktwits
Topics Intellectual Property
News headline image
Here are the top movers in Monday's session. ↗
April 21, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
Most active stocks in Monday's session ↗
April 21, 2025
Stay updated with the latest market activity on Monday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight. 
Via Chartmill
News headline image
Top movers analysis in the middle of the day on 2025-04-21: top gainers and losers in today's session. ↗
April 21, 2025
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
April 21, 2025
 
Via Benzinga
News headline image
The market is filled with gapping stocks in Monday's session. ↗
April 21, 2025
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
News headline image
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
April 21, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
April 14, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
April 11, 2025
 
Via Benzinga
News headline image
Top stock movements in today's session. ↗
April 10, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
Most active stocks in Thursday's session ↗
April 10, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active stocks in today's session. 
Via Chartmill
News headline image
Top movers analysis in the middle of the day on 2025-04-10: top gainers and losers in today's session. ↗
April 10, 2025
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
April 10, 2025
 
Via Benzinga
News headline image
These stocks are gapping in today's session ↗
April 10, 2025
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
News headline image
Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump ↗
April 10, 2025
 
Via Benzinga
News headline image
Which stocks are moving before the opening bell on Thursday? ↗
April 10, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
Dow Tumbles Over 800 Points; US Inflation Rate Falls In March ↗
April 10, 2025
 
Via Benzinga
Topics Economy Stocks
News headline image
Penny Stock ReShape To Distribute FDA-Cleared Neuromuscular Device In US ↗
April 10, 2025
ReShape Lifesciences will distribute Motion Informatics' FDA-cleared Stimel-03 rehab device in the U.S., targeting stroke and injury recovery markets. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
April 10, 2025
 
Via Benzinga
News headline image
US Stocks Likely To Open Lower Ahead Of March Inflation Release: Expert Highlights 'Fairly Weak Returns' After 5%+ Gains In S&P 500 ↗
April 10, 2025
 
Via Benzinga
Topics Economy Stocks
News headline image
Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket ↗
April 10, 2025
 
Via Benzinga
News headline image
Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗
April 09, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
April 09, 2025
 
Via Benzinga
News headline image
ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market
April 09, 2025
ReShape Enters Exclusive U.S. Distribution Agreement in the Neuromuscular Rehabilitation Market 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update
April 07, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
Unusual volume stocks are being observed in Monday's session. ↗
April 07, 2025
These stocks have an unusual volume in today's session 
Via Chartmill
News headline image
Discover the most active stocks in Friday's session. ↗
April 04, 2025
Discover the most active stocks in Friday's session. Stay informed about the stocks that are generating the most trading volume! 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap